Best practice model for the disclosure of results and transparent information on clinical trials

Best Practice Model for the Disclosure of Results and Transparent Information on Clinical Trials
Publication date:  25/06/2008
Publication ref: 
Open access to clinical trial information is becoming increasingly important to policymakers, healthcare professionals, patients and the general public. This document sets out guidance for the pharmaceutical industry to encourage greater transparency about the information gained from clinical trials. It is a working document that will be will be subject to regular review.

Document size: 79KB

Print this page icon Print this page
Please choose the subject of your enquiry from the list below:
Code to enter for submitting the form
Enter the above code here:
Can't read? Try different words.